Dr Louise Schaper at PSA25[/caption]
Content unavailable
Sorry, this content is only available to users that the PSA have verified as healthcare professionals. To learn more, talk to a PSA membership...
Should ibuprofen be used for COVID-19 symptoms?
There is currently no peer-reviewed, published scientific evidence to support a direct link between use of ibuprofen and more severe infection with COVID-19.
Choosing wisely: Antibiotics
In the fourth of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the dispensing of repeat...
Risk factors for long-term opioid misuse
Younger age, substance dependence, mental health histories and higher opioid doses are the risk factors most consistently associated with problematic opioid use
Paediatric risperidone errors prompt TGA safety update
The TGA has tightened dosing advice for the antipsychotic risperidone after an alarming number of overdoses occurred in patients under 18.
Pneumococcal vaccine now in Queensland immuniser pharmacist toolkit
Pharmacist immunisers in Queensland will be the first in Australia to provide the pneumococcal vaccination, and will also be able to administer a COVID-19 vaccine when the first becomes available, the state’s health minister said on Saturday.
